IL84861A - Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent - Google Patents

Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent

Info

Publication number
IL84861A
IL84861A IL84861A IL8486187A IL84861A IL 84861 A IL84861 A IL 84861A IL 84861 A IL84861 A IL 84861A IL 8486187 A IL8486187 A IL 8486187A IL 84861 A IL84861 A IL 84861A
Authority
IL
Israel
Prior art keywords
viscosity
human calcitonin
pharmaceutical composition
swelling agent
increasing swelling
Prior art date
Application number
IL84861A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL84861A publication Critical patent/IL84861A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions in the form of aqueous solutions for the nasal administration of human calcitonin in meterable amounts, a process for the production of these pharmaceutical compositions and their use are described. The pharmaceutical composition contains a) a therapeutically effective amount of human calcitonin or a derivative thereof, b) viscosity-increasing swelling agents and c) an aqueous vehicle optionally containing isotonic additives and/or additional auxiliaries.
IL84861A 1986-12-23 1987-12-17 Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent IL84861A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH520086 1986-12-23

Publications (1)

Publication Number Publication Date
IL84861A true IL84861A (en) 1992-09-06

Family

ID=4289609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84861A IL84861A (en) 1986-12-23 1987-12-17 Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent

Country Status (15)

Country Link
EP (1) EP0277462B1 (en)
JP (1) JPS63166832A (en)
AT (1) ATE75404T1 (en)
AU (1) AU608268B2 (en)
CA (1) CA1322330C (en)
DE (1) DE3778682D1 (en)
DK (1) DK166714B1 (en)
ES (1) ES2032303T3 (en)
GR (1) GR3004585T3 (en)
IL (1) IL84861A (en)
MY (1) MY102411A (en)
NZ (1) NZ223005A (en)
PH (1) PH24802A (en)
PT (1) PT86436B (en)
ZA (1) ZA879593B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
EP0527774A4 (en) * 1990-04-10 1993-03-31 The University Of Melbourne Calcitonin gene related peptide for the treatment of undescended testicles
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles
JP3179538B2 (en) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト Aqueous solution of stable human calcitonin
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
US5968899A (en) * 1994-06-03 1999-10-19 Tsumura & Co. Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
ATE219657T1 (en) * 1998-01-30 2002-07-15 Novartis Consumer Health Sa NASAL SOLUTIONS
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
JP2002154989A (en) * 2000-11-14 2002-05-28 Lion Corp Ophthalmic composition and composition having improved retention of medicine in biological mucosa
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
CH657858A5 (en) * 1983-06-27 1986-09-30 Ciba Geigy Ag SUBSTANCE FROM THE CALCITONINE GROUP.
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
DE3500268A1 (en) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt PREPARATIONS WITH DELAYED EFFECT, METHOD FOR THE PRODUCTION THEREOF AND CORRESPONDING AGENTS FOR THE HUMAN OR. VETERINE MEDICAL APPLICATION
JPS61194034A (en) * 1985-02-25 1986-08-28 Teijin Ltd Powdery composition for transnasal administration

Also Published As

Publication number Publication date
ATE75404T1 (en) 1992-05-15
AU8295587A (en) 1988-06-23
PT86436B (en) 1990-11-20
MY102411A (en) 1992-06-17
AU608268B2 (en) 1991-03-28
JPS63166832A (en) 1988-07-11
NZ223005A (en) 1990-07-26
DK676987D0 (en) 1987-12-22
DK676987A (en) 1988-06-24
CA1322330C (en) 1993-09-21
PH24802A (en) 1990-10-30
EP0277462B1 (en) 1992-04-29
EP0277462A1 (en) 1988-08-10
GR3004585T3 (en) 1993-04-28
ZA879593B (en) 1988-06-22
DK166714B1 (en) 1993-07-05
DE3778682D1 (en) 1992-06-04
ES2032303T3 (en) 1993-02-01
PT86436A (en) 1988-01-01

Similar Documents

Publication Publication Date Title
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
DE3875025D1 (en) COMPOSITION CONTAINING CALCITONIN FOR NASAL ADMINISTRATION.
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
EP0508488A3 (en) Use of inositol triphosphate for the treatment of diseases associated with metal intoxications
IL84861A (en) Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent
MY101784A (en) Novel pharmacological compounds
IL74446A0 (en) Topical pharmaceutical compositions
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
GB1506664A (en) Antiviral compositions
GB2021409A (en) Pharmaceutical composition
DK277387D0 (en) THERAPEUTIC TOPICAL COMPOSITION AGAINST A HYPERPROLIFIING EPITHAL DISEASE
IT8722647A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IL76458A0 (en) Polyether ionophore,its preparation and pharmaceutical and veterinary preparations containing it
ES2029161A6 (en) Process for the preparation of zinc carbocysteinate compositions and their use in hepatopathies.